celecoxib and tegafur
celecoxib has been researched along with tegafur in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bendtsen, VO; Bisgaard, C; Jakobsen, A; Lindebjerg, J; Mortensen, JP; Rafaelsen, SR | 1 |
| Busch, OR; Morak, MJ; Nuyttens, JJ; Padmos, EE; Richel, DJ; Schaake, EE; van der Gaast, A; van Eijck, CH; van Tienhoven, G; Vervenne, WL | 1 |
| Allegrini, G; Arrighi, G; Barletta, MT; Bocci, G; Brandi, G; Canu, B; Chericoni, S; Ciarlo, A; Danesi, R; Di Desidero, T; Di Paolo, A; Falcone, A; Fioravanti, A; Fontana, A; Giusiani, M; Kerbel, RS; Loupakis, F; Lucchesi, S; Masi, G; Orlandi, P | 1 |
| Chen, X; Luo, Z; Meng, C | 1 |
| Chen, HC; Chen, HH; Chen, WT; Chien, CR; Hsiao, CF; Lee, HH; Lin, TC; Lin, TY; Liu, TW; Wang, LW | 1 |
| Chen, Z; Guan, Q; Guo, Q; Li, Q; Liu, M; Wang, J; Wang, Y; Ye, Y; Zhou, Y | 1 |
Trials
4 trial(s) available for celecoxib and tegafur
| Article | Year |
|---|---|
A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Endosonography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pyrazoles; Rectal Neoplasms; Sulfonamides; Tegafur; Treatment Outcome; Uracil | 2008 |
Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Combined Modality Therapy; Female; Humans; Leucovorin; Male; Medication Adherence; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Pyrazoles; Sulfonamides; Tegafur; Uracil | 2011 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chemoradiotherapy, Adjuvant; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Immunohistochemistry; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Pyrazoles; Rectal Neoplasms; Rectum; Sulfonamides; Tegafur; Uracil | 2014 |
A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients: A preliminary, three-center, clinical trial study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Capecitabine; Celecoxib; Chemotherapy, Adjuvant; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrectomy; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Tegafur; Treatment Outcome; Young Adult | 2019 |
Other Studies
3 other study(ies) available for celecoxib and tegafur
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclophosphamide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Pyrazoles; Sulfonamides; Tegafur; Uracil; Vascular Endothelial Growth Factor A | 2012 |
[Inhibitive effect of celecoxib combined with tegafur gimeracil oteracil potassium on the growth of xenograft tumor of gastric cancer in nude mice].
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Humans; Mice; Mice, Nude; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Stomach Neoplasms; Sulfonamides; Tegafur; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |